{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:10:05Z","timestamp":1790439005255,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171132"],"award-info":[{"award-number":["32171132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170984"],"award-info":[{"award-number":["32170984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11064-022-03845-0","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T15:03:55Z","timestamp":1672931035000},"page":"1707-1715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Limin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxia","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"3845_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"key":"3845_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson Pandemic-A call to action. JAMA Neurol 75:9\u201310","journal-title":"JAMA Neurol"},{"key":"3845_CR3","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dionisio","year":"2021","unstructured":"Dionisio PA, Amaral JD, Rodrigues CMP (2021) Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res Rev 67:101263","journal-title":"Ageing Res Rev"},{"key":"3845_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-15-4272-5_2","volume":"1207","author":"J Lu","year":"2020","unstructured":"Lu J, Wu M, Yue Z (2020) Autophagy and Parkinson\u2019s disease. Adv Exp Med Biol 1207:21\u201351","journal-title":"Adv Exp Med Biol"},{"key":"3845_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"JS Park","year":"2018","unstructured":"Park JS, Davis RL, Sue CM (2018) Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep 18:21","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3845_CR6","doi-asserted-by":"publisher","first-page":"e976","DOI":"10.1212\/NXI.0000000000000976","volume":"8","author":"M Dietrich","year":"2021","unstructured":"Dietrich M, Hartung HP, Albrecht P (2021) Neuroprotective properties of 4-aminopyridine. Neurol Neuroimmunol Neuroinflamm 8:e976","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3845_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1212\/CPJ.0000000000000321","volume":"7","author":"M Strupp","year":"2017","unstructured":"Strupp M, Teufel J, Zwergal A, Schniepp R, Khodakhah K, Feil K (2017) Aminopyridines for the treatment of neurologic disorders. Neurol Clin Pract 7:65\u201376","journal-title":"Neurol Clin Pract"},{"key":"3845_CR8","doi-asserted-by":"publisher","first-page":"112988","DOI":"10.1016\/j.expneurol.2019.112988","volume":"320","author":"W Yan","year":"2019","unstructured":"Yan W, Zhang M, Yu Y, Yi X, Guo T, Hu H, Sun Q, Chen M, Xiong H, Chen L (2019) Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro. Exp Neurol 320:112988","journal-title":"Exp Neurol"},{"key":"3845_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/milmed\/usy399","volume":"184","author":"M Noble","year":"2019","unstructured":"Noble M, Tseng KC, Li H, Elfar JC (2019) 4-Aminopyridine as a single Agent Diagnostic and treatment for severe nerve crush Injury. Mil Med 184:379\u2013385","journal-title":"Mil Med"},{"key":"3845_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/jcph.1437","volume":"59","author":"K Peikert","year":"2019","unstructured":"Peikert K, Naumann M, Gunther R, Wegner F, Hermann A (2019) Off-label treatment of 4 amyotrophic lateral sclerosis patients with 4-Aminopyridine. J Clin Pharmacol 59:1400\u20131404","journal-title":"J Clin Pharmacol"},{"key":"3845_CR11","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1007\/s00415-013-7090-0","volume":"260","author":"CC Luca","year":"2013","unstructured":"Luca CC, Singer C (2013) 4-Aminopyridine improves freezing of gait in Parkinson\u2019s disease. J Neurol 260:2662\u20132664","journal-title":"J Neurol"},{"key":"3845_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbr.2011.04.021","volume":"223","author":"H Haghdoost-Yazdi","year":"2011","unstructured":"Haghdoost-Yazdi H, Faraji A, Fraidouni N, Movahedi M, Hadibeygi E, Vaezi F (2011) Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson\u2019s disease. Behav Brain Res 223:70\u201374","journal-title":"Behav Brain Res"},{"key":"3845_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.17712\/nsj.2017.1.20160266","volume":"22","author":"H Haghdoost-Yazdi","year":"2017","unstructured":"Haghdoost-Yazdi H, Piri H, Najafipour R, Faraji A, Fraidouni N, Dargahi T, Alipour Heidari M (2017) Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model. Neurosciences (Riyadh) 22:44\u201350","journal-title":"Neurosciences (Riyadh)"},{"key":"3845_CR14","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18:e13031","journal-title":"Aging Cell"},{"key":"3845_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","volume":"212","author":"H Jiang","year":"2008","unstructured":"Jiang H, Li LJ, Wang J, Xie JX (2008) Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 212:532\u2013537","journal-title":"Exp Neurol"},{"key":"3845_CR16","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1093\/emboj\/20.20.5715","volume":"20","author":"B Liss","year":"2001","unstructured":"Liss B, Franz O, Sewing S, Bruns R, Neuhoff H, Roeper J (2001) Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J 20:5715\u20135724","journal-title":"EMBO J"},{"key":"3845_CR17","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1523\/JNEUROSCI.5069-13.2014","volume":"34","author":"M Subramaniam","year":"2014","unstructured":"Subramaniam M, Althof D, Gispert S, Schwenk J, Auburger G, Kulik A, Fakler B, Roeper J (2014) Mutant alpha-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels. J Neurosci 34:13586\u201313599","journal-title":"J Neurosci"},{"key":"3845_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s12264-020-00508-4","volume":"36","author":"B Xue","year":"2020","unstructured":"Xue B, Li C, Chang X, Jiang H, Shi L, Xie J (2020) Ghrelin reduces A-Type potassium currents in dopaminergic nigral neurons via the PLC\/PKCdelta pathway. Neurosci Bull 36:947\u2013950","journal-title":"Neurosci Bull"},{"key":"3845_CR19","doi-asserted-by":"publisher","first-page":"G815","DOI":"10.1152\/ajpgi.00001.2005","volume":"289","author":"A Grishin","year":"2005","unstructured":"Grishin A, Ford H, Wang J, Li H, Salvador-Recatala V, Levitan ES, Zaks-Makhina E (2005) Attenuation of apoptosis in enterocytes by blockade of potassium channels. Am J Physiol Gastrointest Liver Physiol 289:G815-821","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3845_CR20","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.isci.2021.102431","volume":"24","author":"LM Song","year":"2021","unstructured":"Song LM, Xiao ZX, Zhang N, Yu XQ, Cui W, Xie JX, Xu HM (2021) Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis. iScience 24:102431","journal-title":"iScience"},{"key":"3845_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12264-021-00775-9","volume":"38","author":"LX Li","year":"2022","unstructured":"Li LX, Li YL, Wu JT, Song JZ, Li XM (2022) Glutamatergic neurons in the Caudal Zona Incerta regulate Parkinsonian Motor symptoms in mice. Neurosci Bull 38:1\u201315","journal-title":"Neurosci Bull"},{"key":"3845_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s11481-020-09925-8","volume":"16","author":"T Costa","year":"2021","unstructured":"Costa T, Fernandez-Villalba E, Izura V, Lucas-Ochoa AM, Menezes-Filho NJ, Santana RC, de Oliveira MD, Araujo FM, Estrada C, Silva V, Costa SL, Herrero MT (2021) Combined 1-Deoxynojirimycin and Ibuprofen Treatment decreases microglial activation, phagocytosis and dopaminergic degeneration in MPTP-Treated mice. J Neuroimmune Pharmacol 16:390\u2013402","journal-title":"J Neuroimmune Pharmacol"},{"key":"3845_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/ijnp\/pyaa060","volume":"23","author":"W Rui","year":"2020","unstructured":"Rui W, Li S, Xiao H, Xiao M, Shi J (2020) Baicalein attenuates neuroinflammation by inhibiting NLRP3\/caspase-1\/GSDMD pathway in MPTP Induced mice model of Parkinson\u2019s disease. Int J Neuropsychopharmacol 23:762\u2013773","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03845-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03845-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03845-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T03:43:06Z","timestamp":1682048586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03845-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03845-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}